CNO Financial Group, Inc.

NYSE:CNO Stock Report

Market Cap: US$4.1b

CNO Financial Group Valuation

Is CNO undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CNO when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: CNO ($39.26) is trading below our estimate of fair value ($63.94)

Significantly Below Fair Value: CNO is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for CNO?

Other financial metrics that can be useful for relative valuation.

CNO key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue1.6x
Enterprise Value/EBITDA8.1x
PEG Ratio1.4x

Price to Earnings Ratio vs Peers

How does CNO's PE Ratio compare to its peers?

The above table shows the PE ratio for CNO vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average19.7x
GNW Genworth Financial
32.9xn/aUS$3.1b
GL Globe Life
8.5x3.8%US$9.3b
PRI Primerica
14.5x6.8%US$10.1b
LNC Lincoln National
22.8x19.2%US$6.2b
CNO CNO Financial Group
14.8x10.9%US$4.1b

Price-To-Earnings vs Peers: CNO is good value based on its Price-To-Earnings Ratio (14.8x) compared to the peer average (19.7x).


Price to Earnings Ratio vs Industry

How does CNO's PE Ratio compare vs other companies in the US Insurance Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a10.4%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: CNO is expensive based on its Price-To-Earnings Ratio (14.8x) compared to the US Insurance industry average (13.2x).


Price to Earnings Ratio vs Fair Ratio

What is CNO's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CNO PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio14.8x
Fair PE Ratio14.9x

Price-To-Earnings vs Fair Ratio: CNO is good value based on its Price-To-Earnings Ratio (14.8x) compared to the estimated Fair Price-To-Earnings Ratio (14.9x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst CNO forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$39.26
US$37.60
-4.2%
7.6%US$42.00US$35.00n/a5
Nov ’25US$35.92
US$36.80
+2.4%
9.9%US$42.00US$32.00n/a5
Oct ’25US$34.36
US$33.60
-2.2%
10.2%US$38.00US$29.00n/a5
Sep ’25US$34.92
US$33.20
-4.9%
11.5%US$38.00US$29.00n/a5
Aug ’25US$33.79
US$33.00
-2.3%
11.3%US$38.00US$29.00n/a5
Jul ’25US$27.72
US$29.40
+6.1%
4.6%US$31.00US$27.00n/a5
Jun ’25US$28.69
US$29.00
+1.1%
3.8%US$30.00US$27.00n/a5
May ’25US$26.71
US$29.00
+8.6%
3.8%US$30.00US$27.00n/a5
Apr ’25US$27.20
US$28.80
+5.9%
4.0%US$30.00US$27.00n/a5
Mar ’25US$26.97
US$28.80
+6.8%
4.0%US$30.00US$27.00n/a5
Feb ’25US$26.64
US$27.80
+4.4%
3.5%US$29.00US$26.00n/a5
Jan ’25US$27.90
US$26.80
-3.9%
6.4%US$29.00US$24.00n/a5
Dec ’24US$26.87
US$25.80
-4.0%
5.7%US$28.00US$24.00n/a5
Nov ’24US$23.06
US$25.60
+11.0%
7.2%US$29.00US$24.00US$35.925
Oct ’24US$23.73
US$25.60
+7.9%
7.2%US$29.00US$24.00US$34.365
Sep ’24US$23.78
US$25.40
+6.8%
8.1%US$29.00US$23.00US$34.925
Aug ’24US$24.35
US$25.40
+4.3%
8.1%US$29.00US$23.00US$33.795
Jul ’24US$23.67
US$25.60
+8.2%
9.4%US$30.00US$23.00US$27.725
Jun ’24US$21.69
US$25.33
+16.8%
9.0%US$30.00US$23.00US$28.696
May ’24US$22.75
US$25.17
+10.6%
9.8%US$30.00US$22.00US$26.716
Apr ’24US$22.19
US$26.00
+17.2%
9.7%US$30.00US$22.00US$27.206
Mar ’24US$25.64
US$26.50
+3.4%
7.1%US$30.00US$25.00US$26.976
Feb ’24US$26.11
US$24.17
-7.4%
5.0%US$26.00US$23.00US$26.646
Jan ’24US$22.85
US$23.50
+2.8%
5.4%US$26.00US$22.00US$27.906
Dec ’23US$23.24
US$23.50
+1.1%
5.4%US$26.00US$22.00US$26.876
Nov ’23US$22.09
US$22.83
+3.4%
7.8%US$26.00US$20.00US$23.066

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies